Stay updated on AFM13-NK vs AFM13 in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the AFM13-NK vs AFM13 in Lymphoma Clinical Trial page.

Latest updates to the AFM13-NK vs AFM13 in Lymphoma Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5. This reflects an underlying system update rather than a change to the study data or content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe bibliographic entry for the related Nat Med phase 1 trial was updated to v3.5.4 with the full author list and DOI, and the prior Erratum entry (v3.5.3) was removed to reflect the current revision of the citation.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page shows an updated interface/release revision, changing the displayed version from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded a new publication citation (Nat Med 2025) for Allogeneic NK cells with AFM13-NK and AFM13, including the erratum. Updated the revision to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision: v3.5.0 was added to the site revisions. The v3.4.3 entry was removed.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2 version.SummaryDifference0.1%

Stay in the know with updates to AFM13-NK vs AFM13 in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AFM13-NK vs AFM13 in Lymphoma Clinical Trial page.